Collectively, the miR-125a-5p/BTG2 pathway may serve as a key regulatory mechanism in the pathogenesis of chronic periodontitis, providing a promising molecular target for the development of innovative therapeutic strategies. This evidence concerns the gene BTG2 and periodontitis.